AzTrials
AzTrials

Chronic Instability of JointNCT04108390

Gluteus Medius Dry Needling and Ankle Instability

A study testing Dry needling in people with Chronic Instability of Joint and Trigger Point Pain, Myofascial, run by Universidad Europea de Madrid at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Randomized clinical trial in individuals with chronic ankle instability. Main outcomes were as follows: pain intensity, pressure pain threshold, lower limb balance and range of motion. The sample will be divided in two groups: 1) dry needling at the gluteus medius trigger point (intervention). Read more about this study

Who is it for?
Ages 18 to 50 years
What is being tested?
Dry needling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSpain
Study dates
1 Sep 2019to 25 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • individuals with chronic ankle instability, 20 to 50 years old.

Who cannot join

  • any lower limb disease, fractures, infections, pregnancy, received any treatment in the previous 3 months.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Fiom clinic

    Madrid

Other trials in Spain

About this study

Official title: Effectiveness of Gluteus Medius Dry Needling in Patients With Chronic Ankle Instability

Randomized clinical trial in individuals with chronic ankle instability. Main outcomes were as follows: pain intensity, pressure pain threshold, lower limb balance and range of motion. The sample will be divided in two groups: 1) dry needling at the gluteus medius trigger point (intervention). 2) dry needling 1,5 cm from the gluteus medius trigger point (control).

Read the detailed description

Inclusion criteria will be: individuals with chronic ankle instability, 20 to 50 years old. Exclusion criteria: any lower limb disease, fractures, infections, pregnancy, received any treatment in the previous 3 months.

Initially, the base measurements were as follows: paint intensity, pressure pain threshold at the gluteus medius trigger point, ankle range of motion and balance of the lower limb.

Once baseline measurements will be taken, the same evaluations will be performed at 4 weeks from the start.

Being tested
Dry needling
Keywords
ankle, dry needling, trigger point
Medical subject headings
Myofascial Pain Syndromes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dry needlingOther

    Also called Manual Therapy

    For this intervention, the physiotherapist will be placed a needle in the gluteus medius trigger point from 8 to 15 times.

Study groups in NCT04108390
Study groupRoleWhat they receive
Intervention groupExperimentalIndividuals for this group will be treat with a dry needling intervention at the gluteus medius trigger point.
Receives: Other: Dry needling
Control groupActive comparatorIndividuals for this group will be treat with a dry needling technique at 1,5 cm from the trigger point (not in the trigger point).
Receives: Other: Dry needling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    Individuals reported the pain intensity with the Visual Analogue Scale (VAS scale). The minimum and maximum scores were 0 (no pain) 100 (the worst pain). There was no sub-scales.

    Measured: 1 day

  2. Pain pressure threshold

    Pain pressure threshold were recorded with a pressure algometer. Evaluator press the trigger point with the algometer until the patient feel pain. The outcome will be recorder and expressed in kg/cm2

    Measured: 1 day

Secondary outcomes (2)
  1. Range of motion

    Assess the ankle range of motion with a goniometer.

    Measured: 1 day

  2. Balance

    Assess the lower limb balance with the star excursion balance test

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Sep 2019
  2. Study start1 Sep 2019
  3. Primary completion1 Jan 2020
  4. Study completion25 Mar 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04108390
Sponsor's protocol ID
CIPI/19/012
Status last verified
Jan 2020
First submitted
26 Sep 2019
Last updated
28 Jan 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Dry needling in people with Chronic Instability of Joint and Trigger Point Pain, Myofascial, run by Universidad Europea de Madrid at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: 1 day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in